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Although TGF-β isoforms (TGF-β1-3) display very similar biochemical characteristics in vitro, it has been determined that they demonstrate
different or even opposing effects in vivo. During embryogenesis, TGF-βs play important roles in several developmental processes. Tgfb3 is strongly
expressed in the prefusion palatal epithelium, and mice lacking Tgfb3 display a cleft of the secondary palate. To test whether the effect of TGF-β3 in
palatogenesis is isoform-specific in vivo, we generated a knockin mouse by replacing the coding region of exon1 in the Tgfb3 gene with the full-
length Tgfb1 cDNA, which resulted in the expression of Tgfb1 in the Tgfb3 expressing domain. The homozygote knockin mice display a complete
fusion at the mid-portion of the secondary palate, while the most anterior and posterior regions fail to fuse appropriately indicating that in vivo
replacement of TGF-β3 with TGF-β1 can only partially correct the epithelial fusion defect of Tgfb3 knockout embryos. Palatal shelves of Tgfb1
knockin homozygote mice adhere, intercalate, and form characteristic epithelial triangles. However, decreased apoptosis in the midline epithelium,
slower breakdown of the basement membrane and a general delay in epithelial fusion were observed when compared to control littermates. These
results demonstrate an isoform-specific role for TGF-β3 in the palatal epithelium during palate formation, which cannot be fully substituted with
TGF-β1.
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Cleft palate and cleft lip are among the most common
congenital birth defects in humans occurring once in every 500–
700 births (Murray, 2002; Rice, 2005). While our understanding
of molecular control of palate formation (palatogenesis) has
greatly improved during the last decade, many questions still
remain unanswered (Chai and Maxson, 2006; Schutte and
Murray, 1999). The mammalian secondary palate develops from
bilateral outgrowth of palatal shelves from the maxillary
processes. Two key cell types underlying palatogenesis are
epithelial cells derived from the pharyngeal ectoderm and
mesenchymal cells derived mostly from the neural crest (Dudas
and Kaartinen, 2005; Gritli-Linde, 2007; Schutte and Murray,
1999). The interactions between the ectoderm and the under-⁎ Corresponding author.
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doi:10.1016/j.ydbio.2007.09.034lying mesenchyme promote the vertical growth of palatal
shelves beside the tongue. Accompanied by the enlargement of
the lower jaw and forward displacement of the tongue, palatal
shelves elevate to a horizontal position above the tongue.
Subsequently, they make contact, become adherent, and fuse
(Ferguson, 1988).
Many growth factors, signaling pathways and nuclear factors
have been implicated in palatogenesis (Dudas and Kaartinen,
2005; Gritli-Linde, 2007; Hilliard et al., 2005). Among them,
TGF-βs have been shown to play important roles in regulating
epithelial-mesenchymal interactions leading to appropriate
growth and fusion of palatal shelves (Nawshad et al., 2005);
Tgfb2 is expressed in the palatal mesenchyme, whereas Tgfb1
and Tgfb3 expression was proposed to be limited to the
prefusion palatal midline epithelium (Fitzpatrick et al., 1990;
Pelton et al., 1990). Both Tgfb2 and Tgfb3 knockout mice
display cleft palate phenotypes, which are caused by different
pathogenetic mechanisms (Kaartinen et al., 1995; Martinez-
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Taya et al., 1999). Palatal shelves of Tgfb2 knockout mice fail to
grow and elevate, suggesting a role for TGF-β2 in the growth of
the palatal mesenchyme. Interestingly, palatal shelves of Tgfb3
knockout mice elevate and become apposed but fail to fuse
leading to cleft palate. Although TGF-β1 is also expressed in the
epithelial tips of prefusion palatal shelves, Tgfb1 null mutants do
not display a cleft palate phenotype (Kulkarni et al., 1993; Shull
et al., 1992).
TGF-β isoforms share a high degree of homology in the
mature domain of the growth factor and are qualitatively
indistinguishable in in vitro cell culture assays (Roberts and
Sporn, 1992). During embryogenesis, TGFβ isoforms display
overlapping but distinct expression patterns, and they are often
expressed at sites where commitment of a specific cell fate
occurs (Akhurst et al., 1990; Pelton et al., 1990). Non-
overlapping phenotypes associated with the null mutation of
different TGF-β isoforms suggest that biological activities of
TGF-β isoforms may be different in vivo. Indeed, functional
analyses of the TGF-β isoforms ex vivo have revealed that they
have different, or even opposing, biological activities in certain
model systems (Foitzik et al., 1999; Li et al., 1999; Shah et al.,
1995). In a skin organ culture model, TGF-β1 treatment resulted
in the inhibition of hair follicle development and keratinocyte
proliferation, whereas TGF-β2 treatment potently stimulated
hair follicle formation and concomitantly produced epidermal
hyperplasia (Foitzik et al., 1999). In skin grafts, TGF-β3, but not
TGF-β1, was shown to protect keratinocytes against TPA-
induced cell death (Li et al., 1999). Moreover, in a rat cutaneous
wound healing model, TGF-β1 and TGF-β2 were shown to be
involved in cutaneous scarring, while TGF-β3 acted as an anti-
scarring agent (Shah et al., 1995).
In this study, we tested whether the role of TGF-β3 in vivo
during palatal fusion is isoform specific by replacing the coding
region of exon1 in the Tgfb3 gene with Tgfb1 cDNA using gene-
targeting technology. The resulting Tgfb1-knockin (Tgfb1-KI)
mice, which express Tgfb1 in the Tgfb3 locus and are null for
Tgfb3, displayed a remarkable improvement in the cleft palate
phenotype when compared to Tgfb3 null mutants. Amid-portion
of the secondary palate demonstrated a complete fusion while
the anterior secondary palate still failed to fuse to the primary
palate, and the posterior palate displayed a submucous cleft. The
rate of apoptosis was attenuated and breakdown of the basement
membrane was reduced in Tgfb1-KI samples when compared to
wild-type littermates. These findings demonstrate a partial
isoform-specific role for TGF-β3 in the palatal epithelium
during the development, which cannot be fully compensated by
TGF-β1.
Materials and methods
Gene targeting of Cre cDNA into Tgfb3 locus (Tgfb3-Cre mice)
A targeting vector was generated by combining a 9-kb clone isolated from
the B6xCBA (F1) mouse genomic library (right arm), a 1.6-kb PCR fragment
amplified from the R1-ES cell DNA (left arm), and a cassette containing a
promoterless Cre gene and a neomycin-resistant gene driven by the phospho-
glycerate kinase promoter (PGK-Neo) to replace the coding region of the ATGcontaining exon 1 of the Tgfb3 gene. Briefly, a 1.6-kb PCR-amplified 5′ XbaI–
BamHI genomic fragment, the Cre-pgk-Neo, and a 10-kb 3′ NotI–EcoRI
genomic fragment (generated by fusing a 2.6-kb NotI–Kpn1 PCR fragment
with a 7.6-kb KpnI–EcoRI fragment from the library clone) containing exons 2
and 3 were subcloned into the pKOdt plasmid (Stratagene). R1-ES cells were
cultured, electroporated, and screened as previously described (Kaartinen et al.,
1995; Kaartinen et al., 2004). Targeted colonies were initially identified by PCR
amplification of a 2-kb fragment using a 5′-arm outside sense primer1
(GCATGCTCCAGACTGCCTTGGGA) and a Cre anti-sense primer 2
(CCTCATTCACTCGTTGCATCGACCGG). Southern blot analyses of geno-
mic DNAs, digested with both ClaI and KpnI, were used to confirm
homologous recombination of the targeted allele using the Cre and Neo
probes. A total of 7 positive homologous recombinant ES cells clones were
obtained from 260 G418-resistant clones. ES cells from two independent
targeted clones were microinjected into C57/BL6J blastocysts by the transgenic
core facility at the University of Southern California. Three male chimeras
(male/female ratio was 9:3) were used to produce heterozygote Tgfb3-Cre
mice.
Gene targeting of Tgfb1 cDNA into Tgfb3 locus (Tgfb1-KI mice)
A 1.6-kb PCR-amplified XbaI–BamHI Tgfb3 genomic fragment, a Tgfb1
cDNA with phosphoglycerate kinase (pgk) polyA sequence, a loxP-floxed
neomycin-resistant gene driven by the pgk promoter, and a 10-kb PCR-amplified
NotI–EcoRI genomic fragment containing exons 2 and 3 of Tgfb3 gene were
subcloned into a pKOdt vector (Stratagene). Targeted colonies were initially
identified by PCR amplification of a 2-kb fragment using a 5′-arm outside sense
primer 1 (GCATGCTCCAGACTGCCTTGGGA) and a Tgfb1 anti-sense primer
3 (GGAGTGGGAGCAGAAGCGGCAGTAGCC). Southern blot analysis of
genomic DNAs digested with NheI was used to confirm homologous
recombination of the targeted allele using a Neo probe. One positive homologous
recombinant ES cell clone was obtained from 192 G418-resistant clones. This
cell line produced two highly chimeric males, both of whom were germ line
transmitters.
Mouse breeding, embryo isolation, and genotype assays
ROSA26 Cre reporter mice were obtained from the Jackson laboratory (Bar
Harbor, ME, USA). Tgfb3−/− mice were previous made in the laboratory
(Kaartinen et al., 1995). Tgfb3-Cre and Tgfb1-K mice were generated as
described above. All mice were bred to have a mixed genetic background. Mice
were mated during the dark period of the controlled light cycle and female mice
acquiring vaginal plugs were designated as day 0. At the time interval indicated
in respective figures (E14 to E17), females were euthanized by CO2 and
embryos were collected in PBS (Invitrogen) followed by further analyses. All
studies and procedures performed on mice were carried out at the Animal Care
Facility of the Saban Research Institute and were approved by the CHLA
Animal Care and Use Committee (IACUC). Mice tail biopsies were collected
and genotyped by PCR. For the Tgfb1-KI allele, the following oligos were
used: sense: GAGTCAGAGCCCGGCAGAACCTGTT; antisense:
GCCGGTTACCAAGG TAACGCCAGGA. Oligos for genotyping Cre and
Tgfb3-null alleles have been described elsewhere (Kaartinen et al., 2004; Shi
et al., 1999).
Histological analyses, X-gal staining, scanning electron microscopy
and In situ Hybridization
Mouse embryos or tissues were fixed in 4% formaldehyde for 24 h, and
paraffin sections were stained with hematoxylin–eosin using standard pro-
cedures. Frozen sections of embryos were stained for lacZ activity as described
(Hogan et al., 1994). For scanning electron microscopy analysis, samples were
fixed in 4% formaldehyde plus 0.5% glutaraldehyde for 48 h and processed at the
Tissue Imaging Core in DEI/USC Norris Cancer Center. Pictures were recorded
using a scanning electron microscope with computerized digital capture (Hitachi
S-570). RNA in situ hybridization was performed as previously described
(Moorman et al., 2001). A 455-bp fragment of the mouse Tgfb1 cDNA (nts 206–
661) was subcloned into pBSks, digested with KpnI, and transcribed with T3
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turers' protocol (Boehringer Mannheim).
Organ culture, immunostainings, and TUNEL assays
Palatal shelves were cultured for 48 h in BGJb medium (Invitrogen)
(Kaartinen et al., 1997) and analyzed with serial sectioning. Paraffin sections
were stained for both laminin and K14 using an anti-laminin antibody (1:250,
Sigma) and an anti-K14 antibody (1:250, Lab Vision) (Harlow and Lane, 1988).
Images from the anti-laminin staining (red color) and the anti-K14 staining (green
color) were superimposed using Adobe Photoshop software. Immunostaining for
phospho-Smad2/3 was done in paraffin sections using Phospho-Smad2 Ser465/
467 antibody (1:200, Chemicon), after antigen retrieval by boiling in 10 mMTris
buffer (pH 10). Apoptotic cells were detected in paraffin sections using DeadEnd
Fluorometric TUNEL system (Promega).
Western blotting
Tips of palatal shelves were dissected out from E14 embryos (n=3 for each
genotype) and frozen in an ethanol-dry ice bath. Samples were lysed at 90 °C for
10 min in 40 μl 1% SDS buffer (50 mMTris pH 7.5, 1% SDS, 1 mMEDTA, 10%
Glycerol) plus protease inhibitors (Aprotinin 2 μg/ml, Leupeptin 20 μg/ml,
Pepstatin A 1-μM, PMSF 1 mM) and phosphatase inhibitors (NaF 10 mM,
Sodium Vanadate 1mM). Five micrograms of protein per lane was resolved by
9% SDS–PAGE and electroblotted onto PVDF membrane (Hybond-P,
Amersham). The membrane was blocked and incubated either overnight at
4 °C with diluted anti-phospho Smad2 antibody (Cell signaling, 1:1000 dilution
in blocking solution) or 1 h with diluted anti-Smad2 antibody (Zymed, 1:500
dilution in blocking buffer). The membrane was then probed with horseradish
peroxidase (HRP)-conjugated goat anti-rabbit antibody and developed with HRP
substrate (Immobilon Western, Millipore). The chemiluminescent signal was
exposed to X-ray films and the signal intensity was quantified by densitometric
analysis using Un-Scan it Gel software (Silk Scientific, Inc.). Signal intensities of
phospho-Smad2/3 bands from wild-type and mutant samples were normalized to
signal intensities of Smad2, using the total pixel value obtained by the ‘Un-Scan
it’ gel software.
Total RNA preparation, reverse transcription, and gene expression
analyses
Total RNA was isolated from tips of E14 palatal shelves using the RNeasy
mini kit (Qiagen), and cDNAs were synthesized using the Omniscript reverse
transcription kit (Qiagen) according to the manufacturers' protocols. Real-time
PCR was carried out using a LightCycler 1.5 (Roche) with the LightCycler
Taqman Master mix and Roche universal probe/primer sets for the following
genes: Tgfb1 (mouse universal probe #72, Left primer TGGAGCAACATGTG-
GAACTC, and right primer GTCAGCAGCCGGTTACCA), Tgfb3 (mouse
universal probe #25, left primer CCCTGGACACCAATTACTGC, and right
primer TCAATATAAAGGGGGCGTACA), Mmp-13 (mouse universal probe
#62, left primer CAGTCTCCGAGGAGAAACTATGA, and right primer
GGACTTTGTCAAAAAGAGCTCAG), and β-actin (universal probe #106,
left primer TGACAGGATGCAGAAGGAGA, and right primer CGCTCAG-
GAGGAGCAATG). Relative quantification of gene expression between
samples and absolute quantification of gene expression within a sample were
done using the LightCycler software 4.0. The amplification efficiencies, which
were calculated from standard curves generated by dilutions of cDNA samples at
known concentrations, for Tgfb1, Tgfb3, and β-actin were 1.803, 1.911, and
1.742, respectively.
CHO cell transfection and luciferase reporter assay
The mouse TGF-β1 cDNA was purchased from ATCC (#3586216), PCR-
amplified, and cloned into the pGK plasmid. Three independent bacterial
clones were chosen to transfect the CHO cells using lipofectamine 2000
(Invitrogen). The supernatant from transfected cells was diluted with an equal
volume of DMEM and applied to MLE cells stably integrated with
plasminogen activator inhibitor-1/luciferase reporter plasmid. Luciferaseactivity wasmeasured by using the Luciferase Reporter Assay System (Promega)
with a Luminometer.
Results
Generation of Tgfb1-KI and control Tgfb3-Cre mice
To test whether TGF-β1 is able to substitute for TGF-β3
when expressed in vivo in the Tgfb3-expressing domain, we
used gene targeting to replace the coding region in exon 1 of the
Tgfb3 gene with a full-length cDNA encoding the mouse Tgfb1
gene followed by the loxP-Pgk-Neo-loxP cassette (Fig. 1A).
Since the Tgfb1-KI allele lacks the sequences encoded by Tgfb3
exon 1, and since all the promoter and regulatory elements of the
Tgfb3 gene were essentially preserved, we predicted that (i)
Tgfb1 expression would faithfully recapitulate the endogenous
expression pattern of the Tgfb3 gene and (ii) the Tgfb1-KI allele
would be a true null allele for Tgfb3. First, we verified that our
PCR-generated mouse Tgfb1 cDNA clones produced a biolo-
gically active ligand. Culture media collected from CHO cell
cultures transfected with the Tgfb1 expression vector were
analyzed by the plasminogen activator inhibitor-1/luciferase
reporter assay (Abe et al., 1994). The positive clone #1 was used
to construct the targeting vector, which in turn was used to
generate chimeric mice and subsequently mice heterozygous for
the Tgfb1 knockin allele (Tgfb1-KI) (Fig. 1C).
To prove that the generated Tgfb1-KI allele is a true null allele
for Tgfb3, and that a resultant phenotype is due to an in vivo
replacement of TGF-β3 with TGF-β1, we generated another
mouse line by inserting the promoterless Cre recombinase-Pgk-
Neo cassette into Tgfb3 exon1 by homologous recombination
essentially as described above for the Tgfb1 knockin allele (Fig.
1A). Concordant with the published expression pattern for
Tgfb3 (Fitzpatrick et al., 1990; Pelton et al., 1990), Cre-induced
recombination was strikingly strong in the prefusion palatal
epithelium (Fig. 1D). Moreover, the homozygote Tgfb3-Cre
mice displayed a cleft palate phenotype identical to that of the
previously described Tgfb3 knockout mice (Kaartinen et al.,
1995; Proetzel et al., 1995) confirming that homozygous Tgfb3-
Cre mice were true null mutants for the Tgfb3 gene and
suggesting that the analogous Tgfb1-KI allele is a true null allele
(Fig. 2).
In vivo replacement of TGF-β3 with TGF-β1 leads to a partial
rescue of the Tgfb3-null cleft palate phenotype
Crossing the Tgfb1-KI heterozygote male mice with hetero-
zygote female mice produced an expected Mendelian ratio of
wild-types, heterozygotes, and homozygotes at E14 (n=103)
and at E17 (n=36). However, the homozygote knockin mice
failed to suckle as demonstrated by a complete lack of milk in the
stomach (data not shown). At 2 weeks of age, we could not
detect any surviving homozygote Tgfb1-KI mice (n=45). While
a superficial macroscopic examination of the homozygote
Tgfb1-KI newborn mice failed to demonstrate any obvious
cleft palate phenotypes, detailed scanning electron microscopy
and histological analyses exposed a submucous posterior cleft
Fig. 1. Generation of Tgfb1 knockin and Cre knockin mice. (A) A schematic diagram of Tgfb3 allele and targeting vectors for Tgfb1 knockin (Tgfb1-KI) and Cre
knockin (Tgfb3-Cre). Ex1, Ex2, Ex3: Exon1, Exon2, and Exon3; Tgfb1 cassette: Tgfb1 cDNAwith phosphoglycerate kinase polyA sequence and the pgk promoter
driven neomycin-resistant gene flanked by loxP sites; Cre cassette: the promotorless Cre gene with the neomycin-resistant gene driven by the pgk promoter; Nh: NheI,
K: KpnI, X: XhoI, B: BamHI, E: EcoRI, C: ClaI, N: NotI. (B) A schematic diagram for the targeted alleles. PCR and Southern blot screening strategies are illustrated.
(C) Luciferase reporter assay for PCR-amplified Tgfb1 cDNA. MLE cells stably integrated with plasminogen activator inhibitor-1/luciferase reporter plasmid were
cultured with supernatants from mock transfected cells (Mock) or Tgfb1 cDNA expression plasmid-transfected cells (Tgfb1 cDNA). The supernatant containing
recombinant TGF-β3 at 10 ng/ml served as a positive control (rTGF-β3). Data are presented as raw luciferase values against each supernatant, n=2. (D) A lineage
tracing assay for Tgfb3 expressing cells in the prefusion palate at E14: X-gal staining of the frontal frozen section from Tgfbr3-Cre+/−;R26R+/− embryos. (E, F)
Genotyping of Tgfb1-KI and Tgfb3-Cre mice using PCR analysis.
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Fig. 2. Scanning electron microscopic and histological analyses of palates from wild-type, Tgfb3-Cre homozygote, and Tgfb1 knockin homozygote embryos. (A–C)
Scanning electron microscopic images of palate from wild-type (WT), Tgfb3-Cre homozygote (Tgfb3-Cre Ho), and Tgfb1 knockin homozygote (Tgfb1KI Ho) mice at
E17. A wild-type specimen displays a fully fused palate. Tgfb3-Cre homozygote mouse exhibits a complete bilateral clefting of the secondary palate, whereas the
Tgfb1-KI homozygote mouse only has a cleft on the junction of primary and secondary palate (arrow) and a submucous cleft in the posterior region (arrowhead).
(D–O) Samples from E17 embryos were sectioned serially in the frontal orientation and stained by hematoxylin–eosin. Sections at four different levels are shown for
wild-type (D, G, J, M), Tgfb3-Cre Ho (E, H, K, N), and Tgfb1-KI Ho (F, I, L, O) embryos. In the Tgfb1-KI homozygote sample, the nasal septum fails to fuse with
palatal shelves in the anterior region of the palate (F, arrow); palatal shelves fused in the middle region of the palate with the epithelial islands (I, L; single and double
stars), indicating an ongoing process of palatal fusion; a submucous cleft is present in the posterior region of the palate (O, dotted arrow). In the wild-type sample, the
palatal shelves demonstrate a complete fusion. In the Tgfb3 knockout sample, the palatal shelves display a failure to fuse along the anterior–posterior axis. NS: nasal
septum; P: palatal shelf.
388 L.-T. Yang, V. Kaartinen / Developmental Biology 312 (2007) 384–395and a failure of the primary palate to fuse to the secondary palate
(Fig. 2). It is noteworthy that while the nasal septum failed to
fuse with the anterior palate in homozygote Tgfb1 knockin
embryos, a large segment of the mid-palate displayed complete
epithelial fusion with continuous palatal mesenchyme; a
phenotype seen in neither conventional Tgfb3 knockouts
(Kaartinen et al., 1995; Proetzel et al., 1995) nor epithelial-
specific Tgfb receptor knockouts (Dudas et al., 2006; Xu et al.,
2006).
Tgfb1 is strongly expressed in the tips of palatal shelves in
Tgfb1 knockin mice
The partial rescue seen in the Tgfb1 knockin mice could
result from a failure to achieve an appropriate expression levelof Tgfb1 in the knockin mice. Therefore, we first carefully
quantified Tgfb1 and Tgfb3 mRNAs in developing palates of
embryos derived from the crossing of Tgfb1-KI heterozygote
mice. The tissues composed of both the palatal epithelium and
mesenchyme were dissected from distal tips of prefusion palatal
shelves of wild-type, Tgfb1-KI heterozygote, and homozygote
embryos at E14 (Fig. 3A). Total RNAwas isolated and reverse-
transcribed, and the obtained cDNA was then quantified using
the TaqMan real-time PCR approach (Fig. 3B). In embryos
heterozygous for both the Tgfb1 knockin and the endogenous
Tgfb3 alleles, the level of Tgfb1 mRNA in the distal edges of
palatal shelves was approximately 50% higher, and the level of
Tgfb3 mRNAwas approximately 2-fold lower than the level in
corresponding wild-type samples. In contrast, in homozygous
Tgfb1-KI mice, there was no detectable Tgfb3 expression,
Fig. 3. Gene expression analyses of the Tgfb1 knockin mice. (A) A schematic presentation of prefusion palatal shelves. Distal tips of prefusion palatal shelves to be
dissected for real-time PCR analysis are indicated by a dotted line. NC: nasal cavity, P: palatal shelf, OC: oral cavity. (B) Real-time quantitative PCR analysis for the
expression of Tgfb1 and Tgfb3 in tips of palatal shelves dissected from wild-type (WT), Tgfb1-KI heterozygous (He), and Tgfb1KI homozygous (Ho) embryos at E14.
In embryos heterozygous for the Tgfb1-KI allele, there is a 50% decrease in Tgfb3 expression and a concomitant 50% increase in Tgfb1 expression when compared to
the wild-type sample. In embryos homozygous for the Tgfb1-KI allele, Tgfb3 expression is barely detectable, while expression of Tgfb1 has increased 2-fold when
compared to the wild-type sample. Bar graph: mean±SD, n=3. The expression level of Tgfb1 and Tgfb3 in the wild-type specimen has been arbitrarily set at 1; results
shown are from three independent litters. (C) Real-time absolute quantitative PCR analysis for gene expression of Tgfb1 and Tgfb3 in the tips of wild-type (WT)
prefusion palatal shelves at E14. Bar graph: mean±SD, n=4; Tgfb3 expression has been arbitrarily set at 1. (D) Real-time absolute quantitative PCR analysis for the
expression level of Tgfb1 and Tgfb3 in tips of palatal shelves dissected from Tgfb1KI heterozygotes at E14. Bar graph: mean±SD, n=5; Tgfb3 expression has been
arbitrarily set at 1. (E) In situ hybridization for Tgfb1 in the prefusion palatal shelves of the wild-type and Tgfb1-KI homozygote embryos (n=3). E14 embryos were
processed for serial sectioning in a transverse orientation. Sections from the anterior, the middle, and the posterior region of the palate were hybridized with the Tgfb1
anti-sense probe. The palatal epithelium shows a strong Tgfb1 hybridization signal along the entire anterior–posterior axis (arrow).
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higher than that in the corresponding wild-type sample. These
results indicated that mice with the Tgfb1 knockin allele can
express Tgfb1 mRNA under the control of the endogenous
Tgfb3 promoter.
Next, we dissected tips of prefusion palatal shelves at E14.0
as outlined above and analyzed them using qPCR with an
absolute quantification method to compare Tgfb1 and Tgfb3
expression levels in wild-types and Tgfb1-KI heterozygotes.
Based on standard curves, absolute quantification revealed that
the total level of Tgfb3 expression in wild-type palatal shelves
was about 3-fold higher than that of Tgfb1 (Fig. 3C). An
absolute quantification assay for Tgfb1 and Tgfb3 mRNA
expression was also applied to the Tgfb1-KI heterozygote
samples and the result indicated that Tgfb1 mRNA was
expressed at a level about 2.5-fold higher than Tgfb3 mRNA
(Fig. 3D). In summary, these analyses revealed that the failure of
palatal shelves to fuse appropriately in the homozygote samples
was not caused by defective global expression of Tgfb1 at the
edges of the prefusion palatal shelves.
To verify that the fusion failure in the anterior and posterior
palate was not a result of regional defects in Tgfb1 expression,
we performed in situ hybridization analyses on serial sections of
the control and Tgfb1-KI homozygote embryos at three different
levels (Fig. 3E). The hybridization signal detected in the palatal
epithelium was stronger in the homozygote knockin samples
than in control samples and demonstrated comparable intensity
along the entire anterior–posterior axis.
Tgfb1-KI homozygotes and wild-type controls display a
comparable level of canonical TGF-β signaling activity
Upon TGF-β binding, TGF-β type II receptors, which are
constitutively active, are brought into a complex with type I
receptors and subsequently activate type I receptors, resulting in
the phosphorylation and activation of intracellular effectors
Smad2 and Smad3. To confirm that the Tgfb1-KI allele
generated a functional TGF-β1 protein, we analyzed the
phosphorylation level of Smads2 and -3 (pSmad2/3) in the
midline epithelium of E14 palatal shelves from wild-type,
Tgfb3-Cre homozygote, and Tgfb1-KI homozygote embryos by
immunostaining with an anti-pSmad2/3 antibody (Fig. 4). The
pSmad2/3-positive staining was seen in the periderm and
midline epithelium in wild-type and Tgfb1-KI homozygote
embryos, whereas staining in the midline epithelium of Tgfb3-
Cre homozygote embryos was barely detectable. Importantly,
we did not observe any significant differences in the phosphor-
ylation level of Smad2/3 in the midline epithelium between
wild-type and Tgfb1-KI homozygote embryos in the anterior,
mid- or posterior palate (Fig. 4A). In addition, we dissected tips
of prefusion palatal shelves from wild-type, Tgfb1-KI, and
Tgfb3-Cre homozygote embryos and analyzed their Smad2/3
phosphorylation levels using a quantitative western blot analysis
(Figs. 4B and C). While phosphorylation between wild-type and
Tgfb1-KI samples was comparable, the homozygote Tgfb3-Cre
samples consistently displayed about 10% reduction in phos-
phorylation, when compared to the wild-type controls or Tgfb1-KI samples. The relatively strong, albeit reduced Smad2/3
phosphorylation in Tgfb3 null mutant samples is likely due to the
fact that most of the cells in the harvested tissues were of
mesenchymal origin, which also exhibit phosphorylated Smad2/
3, as can be seen in Fig. 4A. To conclude, these results suggest
that the Tgfb1-KI allele can express a functional protein, and that
in vivo replacement of TGF-β3 with TGF-β1 results in a
comparable level of canonical TGF-β signaling activity.
Palatal shelves of Tgfb1-KI homozygote mice display a delayed
fusion
Palatal shelves isolated from mice lacking TGF-β type I or
type II receptors in the palatal epithelium, as well as palatal
shelves from Tgfb3−/− mice, display a persistent intact midline
seam under organ culture conditions (Dudas et al., 2006;
Kaartinen et al., 1997; Taya et al., 1999; Xu et al., 2006). To
more closely compare the fusion of palatal shelves between
Tgfb1-KI and control mice, we dissected prefusion palatal
shelves from control and mutant embryos and cultured them
under chemically defined conditions in the air-medium interface
for 48 h. The control samples demonstrated an almost complete
fusion characterized by a loss of epithelial cells in the midline
region (Figs. 5A, C, E, G). In contrast, the Tgfb1-KI samples
displayed a midline seam that was only partially degraded
displaying a patchy loss of epithelial cells (Figs. 5B, D, F, H).
Interestingly, the basement membrane was still clearly visible
even in locations where epithelial cells were lost, as demon-
strated by immunostaining for the basement membrane marker
(laminin) and for the epithelial cell marker (cytokeratin-14)
(Figs. 5I–K). To conclude, our organ culture analyses reveal that
the fusion process is significantly delayed in knockin samples
when compared to controls despite the fact that Tgfb1-KI
samples demonstrate a seemingly normal successful fusion in
the mid-palate in vivo.
It has been previously suggested that the disappearance of
midline epithelium requires intensive remodeling of the
extracellular matrix, and that one of the key enzymes in this
process is matrix metalloproteinase-13 (MMP-13), the expres-
sion of which is upregulated in the midline epithelium seam and
the surrounding mesenchyme during palatal fusion (Blavier et
al., 2001). In Tgfb3 knockout mice,Mmp-13 expression domain
is greatly reduced during palatogenesis, suggesting that its
expression is controlled by TGF-β3 (Blavier et al., 2001).
Therefore, we compared Mmp-13 expression in the tips of
palatal shelves between wild-type and Tgfb1-KI samples (Fig.
5L). Our quantitative real-time PCR analysis demonstrated that
misexpression of Tgfb1 in the Tgfb3 locus failed to restore
Mmp-13 expression in Tgfb1-KI homozygous samples to the
level seen in wild-type littermates.
Palatal shelves of Tgfb1-KI homozygotes become adherent but
display reduced apoptosis in the midline palatal epithelium
during palatal fusion
Previous studies have emphasized the importance of inter-
calation of the apposing epithelia as a necessary initial step
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apoptosis as a main mechanism for the removal of the midline
epithelium during subsequent stages of palatogenesis (Cuervo et
al., 2002). Therefore, we examined both the histology and
apoptosis of the midline epithelium seam during the fusion in
Tgfb1-KI homozygote, Tgfb3-Cre homozygote, and control
embryos (Fig. 6). Histological analysis of frontal sectionsFig. 4. Comparison of the phospho-Smad2/3 state in the midline palatal epithelium. (
Cre Ho, right panel), and Tgfb1-KI homozygote (Tgfb1-KI Ho, mid-panel) were imm
Smad3 (anterior to posterior from top to bottom). In wild-type and Tgfb1-KI Ho samp
display a strong positive signal (arrows left and mid-panels), whereas in the Tgfb3-Cr
harvested from tips of prefusion palatal shelves were analyzed for Smad2/3 phosph
histogram represents the relative quantitation of the scanned images. The wild-typeshowed that apposing palatal shelves of control and Tgfb1-KI
homozygote samples became adherent, and that the midline
epithelia were able to intercalate and form comparable oral and
nasal epithelial triangles. In contrast, palatal shelves of Tgfb3-
Cre homozygote samples made contact but failed to intercalate
and form epithelial triangles. TUNEL assays showed that control
samples exhibited a large number of apoptotic cells, particularlyA) Paraffin sections from wild-type (left panel), Tgfb3-Cre homozygote (Tgfb3-
unostained with a phospho-specific antibody against phosphorylated Smad2 and
les, cells in the periderm, palatal epithelium and in the nasal septum (epithelium)
e sample (right panel) the pSmad2/3 staining is undetectable (n=3). (B) Tissues
orylation using western blotting with anti-phopho-Smad2/3 antibodies. (C) The
(control) phospho-Smad2/3 to Smad2/3 ratio was arbitrarily set at 1 (n=3).
Fig. 5. Comparison of the palatal fusion between Tgfb1-KI homozygote and control embryos in vitro. Prefusion palatal shelves were dissected from E14 embryos,
cultured under chemically defined conditions for 48 h and analyzed using serial sectioning. Wild-type (A, C, E) and Tgfb1-KI homozygote (B, D, F) samples were
sectioned at three different levels and stained with hematoxylin and eosin. (G, H), higher magnification of the rectangular regions indicated in the (C, D). In control
samples, the midline seam disappears with only a few epithelial islands left, indicating an almost complete fusion (G). In Tgfβ1-KI homozygous samples, the midline
seam is in the process of breaking down, displaying a patchy loss of epithelial cells (H). The basement membrane is visible even at sites where the epithelial seam is
breaking down (arrows in panel H). (I–K) Paraffin sections from the palatal shelf organ culture of Tgfb1-KI homozygote were immunostained for laminin (M) and K14
(N). The superimposed image is shown in panel K. Arrows in panels J and K point out the breakdown of the midline epithelial seam. (L) Real-time quantitative PCR
analysis of Mmp-13 expression in tips of palatal shelves dissected from wild-type (WT) and Tgfb1-KI homozygote (Tgfb1-KI Ho) embryos at E14. Mmp-13
expression in the Tgfb1KI homozygote is about 30% of that expressed in the wild-type. Bar graph: mean±SD, n=3; WT level has been arbitrarily set at 1.
392 L.-T. Yang, V. Kaartinen / Developmental Biology 312 (2007) 384–395in the nasal and oral epithelial triangles along the anterior–
posterior axis, while a number of apoptotic nuclei were clearly
detectable, but notably reduced in Tgfb1-KI samples. As a
negative control, Tgfb3-Cre homozygote samples did not show
any TUNEL-positive cells. Therefore, attenuated apoptosis
rather than reduced adherence likely accounts for the delayed
fusion of Tgfb1-KI palatal shelves.
Discussion
During palatogenesis, TGFβ signaling is involved in the
appropriate growth of palatal shelves and disappearance of the
midline epithelial seam (Hay, 1995;Nawshad et al., 2004;Shuler,
1995;Young et al., 2000). Despite specific expression of both the
Tgfb1 and Tgfb3 genes in distal edges of the prefusion palatal
shelves, particularly in the medial edge epithelium, endogen-
ously expressed Tgfb1 is not able to rescue the cleft palatephenotype caused by the lack of Tgfb3. Yet, mice heterozygous
for the Tgfb3-null allele have normal palate formation. Whether
this failure to rescue the Tgfb3 null phenotype was due to in vivo
isoform-specific effects or simply reflected a significant
difference in gene expression was not previously known.
Given that three specific isoforms of TGF-β exhibit distinct
and also overlapping expression patterns during development of
different organs, we believe that use of the endogenous Tgfb3
locus to express Tgfb1 is the most reliable strategy to address the
question of functional interchangeability.
Mice homozygous for Tgfb3-Cre allele displayed a cleft
palate phenotype identical to that of the previously described
Tgfb3 knockout mice. Since an identical strategy was used to
generate the Tgfb1-KI and Tgfb3-Cre alleles, it can be deduced
that the Tgfb1-KI allele is also a true null allele for Tgfb3, and
that the partially fused palatal phenotype in Tgfb1-KI embryos is
due to in vivo replacement of TGF-β3 with TGF-β1. Moreover,
Fig. 6. Histological analysis and TUNEL assays on palatal shelves from control, Tgfb3-Cre homozygote, and Tgfb1-KI homozygote mice. Embryos of each genotype
indicated were harvested at E14 and sectioned serially (frontal orientation). (A–C) Histological analysis of frontal sections at comparable levels, staining with
hematoxylin and eosin. Palatal shelves of Tgfb3-Cre homozygote made contact but failed to adhere and form epithelial triangles (B). In contrast, palatal shelves of the
Tgfb1-KI homozygote (C) were adherent and formed epithelial triangles, which were similar to those from the control sample (A). (D–L) TUNEL assays on frontal
sections at three different levels from each genotype (n=3). The Tgfb1-KI homozygote sample (F, I, L) exhibits a reduced number of apoptotic cells when compared to
a control (D, G, J). Apoptotic cells were undetectable in the midline epithelium of the Tgfb3-Cre homozygote sample (E, H, K).
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mRNA under the control of the endogenous Tgfb3 promoter by
analyzing the level of Tgfb1 and Tgfb3 mRNA expression in
distal tips palatal shelves isolated from wild-type, Tgfb1-KI
heterozygote and homozygote embryos. In addition, our real-
time absolute quantitative PCR data showed that Tgfb1 was
expressed at an approximately 2.5-fold higher level than Tgfb3
in heterozygote Tgfb1-KI mice. Given that a total level of Tgfb3
expression in wild-type palatal shelves was about 3-fold higher
than that of Tgfb1, quantitative PCR data of Tgfb1-KI
heterozygote samples reveal that Tgfb1 mRNA expressed in
distal edges of prefusion palatal shelves in homozygote Tgfb1-
KI embryos is at a comparable level to that of Tgfb3 in wild-type
embryos. Furthermore, we detected similar phospho-Smad2/3
levels in midline epithelium between wild-type and Tgfb1-KI
homozygote embryos. Taken together, our experiments indicate
that the failure of TGF-β1 to fully substitute for the function ofTGF-β3 in palatogenesis does not result from an inadequate
level of gene expression and subsequent protein synthesis.
Our in vivo and in vitro experiments suggest that the fusion
process is delayed in Tgfb1-KI homozygotes, leading to a
partially fused palatal phenotype. During palatogenesis, the mid-
anterior portion of palatal shelves make contact first, and the
anterior and posterior parts come in contact later, displaying
slightly rounded contact surface between the two opposing
palatal shelves (Dudas and Kaartinen, 2005). As the fusion
progresses, the midline epithelial seam gradually disappears
along the sites where contact was first established, leading to a
tighter contact between the opposing shelves and enabling closer
contact between other parts of the palate. Delayed epithelial
fusion in Tgfb1-KI samples, characterized by attenuated
apoptosis and slower breakdown of the basement membrane,
may provide a scenario for an in vivo situation, where the
anterior and the posterior parts of the midline seam are
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stretched by a lateral growth of the head, resulting in the anterior
cleft and the posterior submucous cleft. However, our present do
not rule out the possibility that TGF-β3 plays an isoform-
specific role in the most anterior and posterior regions of the
palate. Interestingly, it has been reported that addition of TGF-
β3 induced the formation of filopodia-like structures in the
palatal epithelium in vitro, while TGF-β1 and TGF-β2 were
relatively inefficient in inducing filopodia, but rather induced
lamellipodia in organ cultures (Taya et al., 1999). Perhaps,
filopodia-like structures, which are more efficiently produced by
TGF-β3 play a particularly significant role in the fusion of these
regions, which fail to fuse in Tgfb1-KI embryos.
Mice deficient in TGF-β3, including both the traditional
Tgfb3 knockout mice (Kaartinen et al., 1995; Proetzel et al.,
1995) and the new Tgfb3-Cre knockin mice described in this
study, display either complete clefting of the secondary palate, or
posterior clefting and superficial anterior adherence. A spectrum
of cleft palate phenotypes can also be seen in humans; these vary
from a total cleft to a submucous posterior cleft, and even to bifid
uvula, which can be viewed as the mildest form of oral fusion
defects (Dudas and Kaartinen, 2005). The etiology of these
conditions is currently not well understood. We demonstrated
that in vivo replacement of TGF-β3 with TGF-β1 results in a
consistent mild cleft phenotype, characterized by an anterior
small cleft and a posterior submucous cleft. At the molecular
level, the knockin TGF-β1 can restore the Smad-dependent
TGF-β signaling activity in the Tgfb3−/− background, while it
cannot restore the Mmp13 level to that of the wild-type
littermate. Despite the fact that TGF-β1 exerted an opposing
effect to TGF-β3 in a rat cutaneousmodel (Shah et al., 1995), the
partially rescued cleft palate phenotype seen in Tgfb1-KI
homozygotes demonstrates that TGF-β1 and -β3 have partially
overlapping functions in the palatal epithelium. This is
consistent with earlier studies, which have demonstrated that
addition of TGF-β1 or TGF-β2 can induce an almost complete
fusion of Tgfb3−/− palatal shelves in organ cultures in vitro
(Taya et al., 1999). Taken together, data from our present study
suggest that mildly perturbed developmental signals may lead to
less severe cleft palate phenotypes. Since mice lacking both
alleles of Tgfb1 do not exhibit a cleft palate phenotype, it would
be of interest to know, what is the role of TGF-β1 in the
prefusion palatal epithelium? TGF-β1may play an auxiliary role
secondary to TGF-β3 during palatogenesis by fine-tuning the
signaling field setup by TGF-β3, or it may compensate for the
haploid deficiency of Tgfb3 since Tgfb3 heterozygotes do not
display cleft palate. However, there may be cell type-specific
differences in the processing and activation of TGF-β
precursors, which may, in part, explain the observed differences
between the effects of TGF-β1 and -β3 in the palatal epithelium.
To conclude, our experiments demonstrate that TGF-β
isoforms display cell-type-specific differences during palato-
genesis in vivo. We propose that in some cell types overlapping
expression patterns may modulate the strength of signaling
rather than create a field for signal specificity, while in other cell
types, e.g., the palatal epithelium, there can be notable dif-
ferences between the action of different isoforms.Acknowledgments
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